By NewsDesk @bactiman63

The Brazil Ministry of Health hit several COVID-19 milestones Saturday. First, they became the second country to top the three million mark in COVID-19 cases (3,012,412 confirmed cases), including 621,731 cases in Sao Paulo, and the second country to record 100,000 deaths (100,477).

In addition, Brazil has also recorded that more than 2 million people have recovered from the disease (2,094,293 ), which represents about 70 percent of the country’s total cases.

The government also announced that they are monitoring cases of Pediatric Inflammatory Multisystemic Syndrome in children and adolescents, between 7 months and 16 years.

The objective is to identify whether the syndrome may be related to Covid-19. This is a health surveillance measure. Therefore, in the last week, the Ministry of Health implemented the notification of these cases in the monitoring systems, as well as having conversations with the health departments of the states and municipalities to guide the diagnosis and care of possible cases by health professionals through the identification of the most common signs and symptoms.

Through July, 71 cases were registered in four states: 29 in the state of Ceará, 22 in Rio de Janeiro, 18 in Pará and 2 in Piauí, in addition to three deaths in the state of Rio de Janeiro.

Most of the reported cases had laboratory tests that indicated current or recent infection with SARS-CoV-2 (by molecular biology or serology) or epidemiological link with confirmed case of Covid-19.

The World Health Organization (WHO) had already issued a global alert to pediatricians reporting the identification of a new clinical condition, possibly associated with Covid-19, characterized by the Multisystemic Inflammatory Syndrome, with clinical manifestations similar to the syndrome of Typical Kawasaki, incomplete Kawasaki and / or toxic shock syndrome. Among the most frequent symptoms are persistent fever accompanied by a set of symptoms such as low blood pressure, conjunctivitis, spots on the body, diarrhea, abdominal pain, nausea, vomiting, respiratory impairment, among others.